Drug Interaction Report

Darolutamide and Grazoprevir: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Darolutamide

Nubeqa Nubeqa®
+

Grazoprevir

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Aug 8, 2026
LinkedIn
Interaction severity
Contraindicated
These should generally not be used together.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 105 documented Darolutamide interactions, 13 are rated contraindicated — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
Onset
unspecified
Evidence
probable
Severity
Contraindicated

What happens

Increased grazoprevir exposure and an increased risk of ALT elevation

Interaction Deep Dive

Concomitant use of grazoprevir with OATP1B1/3 inhibitors is contraindicated, as increases in grazoprevir plasma concentrations may increase grazoprevir-related side effects, including ALT elevations. In single-dose studies, coadministration of rifAMPin 600 mg IV with grazoprevir 200 mg in 12 healthy participants resulted in an increased grazoprevir AUC by 10.21-fold and Cmax by 10.94-fold. Similarly, when rifAMPin 600 mg orally was coadministered with grazoprevir 200 mg once daily in 12 healthy participants, grazoprevir AUC increased 8.35-fold and Cmax 6.52-fold. And when cycloSPORINE 400 mg single dose was coadministered with grazoprevir 200 mg once daily, the AUC of grazoprevir increased by 15.21-fold and the Cmax of grazoprevir increased by 17-fold1.

Why it happens (mechanism)

Inhibition of OATP1B1-mediated efflux transport of grazoprevir; inhibition of OATP1B3-mediated efflux transport of grazoprevir

Literature reports

2 reports — tap to read

a) When cycloSPORINE (OATP1B1/3 inhibitor) 400 mg single dose was coadministered with grazoprevir 200 mg once daily, the AUC of grazoprevir increased by 15.21-fold and the Cmax of grazoprevir increased by 17-fold 1.

b) In single-dose studies, coadministration of rifAMPin 600 mg IV with grazoprevir 200 mg in 12 healthy participants resulted in an increased grazoprevir AUC by 10.21-fold and Cmax by 10.94-fold. Similarly, when rifAMPin 600 mg orally was coadministered with grazoprevir 200 mg once daily in 12 healthy participants, grazoprevir AUC increased 8.35-fold and Cmax 6.52-fold 1.

Common questions

Can I take Darolutamide and Grazoprevir together?

Increased grazoprevir exposure and an increased risk of ALT elevation Always confirm with your pharmacist or prescriber before making any change.

How serious is the Darolutamide and Grazoprevir interaction?

It is rated contraindicated. These should generally not be used together.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Questions for your pharmacist

  • Does my dose of Darolutamide or Grazoprevir need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: ZEPATIER(R) oral tablets, elbasvir grazoprevir oral tablets. Merck Sharp & Dohme Corp (per FDA), Whitehouse Station, NJ, 2021. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.